The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Halal Vaccine-Global Market Insights and Sales Trends 2024
Synopsis
Halal vaccines are products in compliance with Shariah law and do not contain any raw materials from porcine origin, alcohol, and are non-toxic. Halal vaccines are processed in separate manufacturing units to avoid any cross contamination.
The global Halal Vaccine market size is expected to reach US$ 1003.2 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Halal Vaccine in various end use industries. The expanding demands from the Government institutions, Hospitals and NGOs,, are propelling Halal Vaccine market. Measles-Rubella Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningococcal Meningitis Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Halal Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Halal Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Halal Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Halal Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Halal Vaccine covered in this report include Al Jomaih Group, Bio Farma, Pfizer, Sinovac, Pharmaniaga, SaudiVax, Novartis and AstraZeneca, etc.
The global Halal Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Al Jomaih Group
Bio Farma
Pfizer
Sinovac
Pharmaniaga
SaudiVax
Novartis
AstraZeneca
Global Halal Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Halal Vaccine market, Segment by Type:
Measles-Rubella Vaccine
Meningococcal Meningitis Vaccine
Others
Global Halal Vaccine market, by Application
Government institutions
Hospitals
NGOs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Halal Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Halal vaccines are products in compliance with Shariah law and do not contain any raw materials from porcine origin, alcohol, and are non-toxic. Halal vaccines are processed in separate manufacturing units to avoid any cross contamination.
The global Halal Vaccine market size is expected to reach US$ 1003.2 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Halal Vaccine in various end use industries. The expanding demands from the Government institutions, Hospitals and NGOs,, are propelling Halal Vaccine market. Measles-Rubella Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Meningococcal Meningitis Vaccine segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Halal Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Halal Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Halal Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Halal Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Halal Vaccine covered in this report include Al Jomaih Group, Bio Farma, Pfizer, Sinovac, Pharmaniaga, SaudiVax, Novartis and AstraZeneca, etc.
The global Halal Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Al Jomaih Group
Bio Farma
Pfizer
Sinovac
Pharmaniaga
SaudiVax
Novartis
AstraZeneca
Global Halal Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Halal Vaccine market, Segment by Type:
Measles-Rubella Vaccine
Meningococcal Meningitis Vaccine
Others
Global Halal Vaccine market, by Application
Government institutions
Hospitals
NGOs
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Halal Vaccine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Halal Vaccine
1.1 Halal Vaccine Market Overview
1.1.1 Halal Vaccine Product Scope
1.1.2 Halal Vaccine Market Status and Outlook
1.2 Global Halal Vaccine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Halal Vaccine Market Size by Region (2018-2029)
1.4 Global Halal Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Halal Vaccine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Halal Vaccine Market Size (2018-2029)
1.6.1 North America Halal Vaccine Market Size (2018-2029)
1.6.2 Europe Halal Vaccine Market Size (2018-2029)
1.6.3 Asia-Pacific Halal Vaccine Market Size (2018-2029)
1.6.4 Latin America Halal Vaccine Market Size (2018-2029)
1.6.5 Middle East & Africa Halal Vaccine Market Size (2018-2029)
2 Halal Vaccine Market by Type
2.1 Introduction
2.1.1 Measles-Rubella Vaccine
2.1.2 Meningococcal Meningitis Vaccine
2.1.3 Others
2.2 Global Halal Vaccine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Halal Vaccine Historic Market Size by Type (2018-2023)
2.2.2 Global Halal Vaccine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Halal Vaccine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Halal Vaccine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Halal Vaccine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Halal Vaccine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Halal Vaccine Revenue Breakdown by Type (2018-2029)
3 Halal Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Government institutions
3.1.2 Hospitals
3.1.3 NGOs
3.2 Global Halal Vaccine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Halal Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Halal Vaccine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Halal Vaccine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Halal Vaccine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Halal Vaccine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Halal Vaccine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Halal Vaccine Revenue Breakdown by Application (2018-2029)
4 Halal Vaccine Competition Analysis by Players
4.1 Global Halal Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Halal Vaccine as of 2022)
4.3 Date of Key Players Enter into Halal Vaccine Market
4.4 Global Top Players Halal Vaccine Headquarters and Area Served
4.5 Key Players Halal Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Halal Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Al Jomaih Group
5.1.1 Al Jomaih Group Profile
5.1.2 Al Jomaih Group Main Business
5.1.3 Al Jomaih Group Halal Vaccine Products, Services and Solutions
5.1.4 Al Jomaih Group Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 Al Jomaih Group Recent Developments
5.2 Bio Farma
5.2.1 Bio Farma Profile
5.2.2 Bio Farma Main Business
5.2.3 Bio Farma Halal Vaccine Products, Services and Solutions
5.2.4 Bio Farma Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 Bio Farma Recent Developments
5.3 Pfizer
5.3.1 Pfizer Profile
5.3.2 Pfizer Main Business
5.3.3 Pfizer Halal Vaccine Products, Services and Solutions
5.3.4 Pfizer Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 Sinovac Recent Developments
5.4 Sinovac
5.4.1 Sinovac Profile
5.4.2 Sinovac Main Business
5.4.3 Sinovac Halal Vaccine Products, Services and Solutions
5.4.4 Sinovac Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 Sinovac Recent Developments
5.5 Pharmaniaga
5.5.1 Pharmaniaga Profile
5.5.2 Pharmaniaga Main Business
5.5.3 Pharmaniaga Halal Vaccine Products, Services and Solutions
5.5.4 Pharmaniaga Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 Pharmaniaga Recent Developments
5.6 SaudiVax
5.6.1 SaudiVax Profile
5.6.2 SaudiVax Main Business
5.6.3 SaudiVax Halal Vaccine Products, Services and Solutions
5.6.4 SaudiVax Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 SaudiVax Recent Developments
5.7 Novartis
5.7.1 Novartis Profile
5.7.2 Novartis Main Business
5.7.3 Novartis Halal Vaccine Products, Services and Solutions
5.7.4 Novartis Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.7.5 Novartis Recent Developments
5.8 AstraZeneca
5.8.1 AstraZeneca Profile
5.8.2 AstraZeneca Main Business
5.8.3 AstraZeneca Halal Vaccine Products, Services and Solutions
5.8.4 AstraZeneca Halal Vaccine Revenue (US$ Million) & (2018-2023)
5.8.5 AstraZeneca Recent Developments
6 North America
6.1 North America Halal Vaccine Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Halal Vaccine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Halal Vaccine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Halal Vaccine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Halal Vaccine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Halal Vaccine Market Dynamics
11.1 Halal Vaccine Industry Trends
11.2 Halal Vaccine Market Drivers
11.3 Halal Vaccine Market Challenges
11.4 Halal Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
